Deutsch
Deutschland
Anmelden
Tipp von eurobuch.com
Ähnliche Bücher
Weitere, andere Bücher, die diesem Buch sehr ähnlich sein könnten:
Buch verkaufen
Anbieter, die das Buch mit der ISBN 9780226045511 ankaufen:
Suchtools
Buchtipps
Aktuelles
FILTER
- 0 Ergebnisse
Kleinster Preis: 5,74 €, größter Preis: 13,46 €, Mittelwert: 10,42 €
Genentech - Hughes, Sally Smith
Vergriffenes Buch, derzeit bei uns nicht verfügbar.
(*)
Hughes, Sally Smith:
Genentech - neues Buch

ISBN: 9780226045511

ID: 781657

In the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price escalate from $35 to $89 in the first few minutes of trading, at that point the largest gain in stock market history. Coming at a time of economic recession and declining technological competitiveness in the United States, the event provoked banner headlines and ignited a period of speculative frenzy over biotechnology as a revolutionary means for creating new and better kinds of pharmaceuticals, untold profit, and a possible solution to national economic malaise.   Drawing from an unparalleled collection of interviews with early biotech players, Sally Smith Hughes offers the first book-length history of this pioneering company, depicting Genentech's improbable creation, precarious youth, and ascent to immense prosperity. Hughes provides intimate portraits of the people significant to Genentech's science and business, including cofounders Herbert Boyer and Robert Swanson, and in doing so sheds new light on how personality affects the growth of science. By placing Genentech's founders, followers, opponents, victims, and beneficiaries in context, Hughes also demonstrates how science interacts with commercial and legal interests and university research, and with government regulation, venture capital, and commercial profits.   Integrating the scientific, the corporate, the contextual, and the personal, Genentech tells the story of biotechnology as it is not often told, as a risky and improbable entrepreneurial venture that had to overcome a number of powerful forces working against it.   Business Business eBook, University of Chicago Press

Neues Buch Ebooks.com
Versandkosten:zzgl. Versandkosten.
Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.
Genentech: The Beginnings of Biotech (Paperback) - Sally Smith Hughes
Vergriffenes Buch, derzeit bei uns nicht verfügbar.
(*)
Sally Smith Hughes:
Genentech: The Beginnings of Biotech (Paperback) - Taschenbuch

2013, ISBN: 022604551X

ID: 18093191764

[EAN: 9780226045511], Neubuch, [PU: The University of Chicago Press, United States], Language: English . Brand New Book. In the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price escalate from $35 to $89 in the first few minutes of trading, at that point the largest gain in stock market history. Coming at a time of economic recession and declining technological competitiveness in the United States, the event provoked banner headlines and ignited a period of speculative frenzy over biotechnology as a revolutionary means for creating new and better kinds of pharmaceuticals, untold profit, and a possible solution to national economic malaise. Drawing from an unparalleled collection of interviews with early biotech players, Sally Smith Hughes offers the first book-length history of this pioneering company, depicting Genentech s improbable creation, precarious youth, and ascent to immense prosperity. Hughes provides intimate portraits of the people significant to Genentech s science and business, and in doing so sheds new light on how personality affects the growth of science. By placing Genentech s founders, followers, opponents, victims, and beneficiaries in context, Hughes also demonstrates how science interacts with commercial and legal interests and university research, and with government regulation, venture capital, and commercial profits. Genentech tells the story of biotechnology as it is not often told, as a risky and improbable entrepreneurial venture that had to overcome a number of powerful forces working against it.

Neues Buch Abebooks.de
The Book Depository US, London, United Kingdom [58762574] [Rating: 5 (von 5)]
NEW BOOK. Versandkosten: EUR 0.56
Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.
Genentech
Vergriffenes Buch, derzeit bei uns nicht verfügbar.
(*)
Genentech - neues Buch

ISBN: 9780226045511

ID: 9780226045511

In the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price escalate from $35 to $89 in the first few minutes of trading, at that point the largest gain in stock market history. Coming at a time of economic recession and declining technological competitiveness in the United States, the event provoked banner headlines and ignited a period of speculative frenzy over biotechnology as a revolutionary means for creating new and better kinds of pharmaceuticals, untold profit, and a possible solution to national economic malaise.Drawing from an unparalleled collection of interviews with early biotech players, Sally Smith Hughes offers the first book-length history of this pioneering company, depicting Genentech's improbable creation, precarious youth, and ascent to immense prosperity. Hughes provides intimate portraits of the people significant to Genentech's science and business, including cofounders Herbert Boyer and Robert Swanson, and in doing so sheds new light on how personality affects the growth of science. By placing Genentech's founders, followers, opponents, victims, and beneficiaries in context, Hughes also demonstrates how science interacts with commercial and legal interests and university research, and with government regulation, venture capital, and commercial profits.Integrating the scientific, the corporate, the contextual, and the personal,Genentech tells the story of biotechnology as it is not often told, as a risky and improbable entrepreneurial venture that had to overcome a number of powerful forces working against it. Books, [PU: University of Chicago Press]

Neues Buch Wordery.com
Nr. Versandkosten:, , zzgl. Versandkosten.
Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.
Genentech : The Beginnings of Biotech - Sally Smith Hughes
Vergriffenes Buch, derzeit bei uns nicht verfügbar.
(*)
Sally Smith Hughes:
Genentech : The Beginnings of Biotech - gebrauchtes Buch

1980, ISBN: 022604551X

ID: 8518707

In the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price escalate from $35 to $89 in the first few minutes of trading, at that point the largest gain in stock market history. Coming at a time of economic recession and declining technological competitiveness in the United States, the event provoked banner headlines and ignited a period of speculative frenzy over biotechnology as a revolutionary means for creating new and better kinds of pharmaceuticals, untold profit, and a possible solution to national economic malaise. Drawing from an unparalleled collection of interviews with early biotech players, Sally Smith Hughes offers the first book-length history of this pioneering company, depicting Genentech's improbable creation, precarious youth, and ascent to immense prosperity. Hughes provides intimate portraits of the people significant to Genentech's science and business, including cofounders Herbert Boyer and Robert Swanson, and in doing so sheds new light on how personality affects the growth of science. By placing Genentech's founders, followers, opponents, victims, and beneficiaries in context, Hughes also demonstrates how science interacts with commercial and legal interests and university research, and with government regulation, venture ca biography and history,biological sciences,biotechnology,business,business and investing,company profiles,engineering,history and philosophy,industries and professions,science Biotechnology, University of Chicago Press

gebrauchtes bzw. antiquarisches Buch Thriftbooks.com
used. Versandkosten:zzgl. Versandkosten.
Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.
Genentech: The Beginnings Of Biotech (Synthesis (University of Chicago)) - Sally Smith Hughes
Vergriffenes Buch, derzeit bei uns nicht verfügbar.
(*)
Sally Smith Hughes:
Genentech: The Beginnings Of Biotech (Synthesis (University of Chicago)) - Taschenbuch

2011, ISBN: 022604551X

[SR: 259191], Paperback, [EAN: 9780226045511], University of Chicago Press, University of Chicago Press, Book, [PU: University of Chicago Press], 2011-10-19, University of Chicago Press, Genentech In the fall of 1980, Genentech, Inc, a little-known California genetic engineering company, became the overnight darling of Wall Street, raising $38 million in its initial public stock offering. This title provides portraits of the people significant to Genentech's science and business, and focuses on how personality affects the growth of science. Full description, 659900, Business & Economic History, 659886, Biographies & Histories, 68, Business, Finance & Law, 1025612, Subjects, 266239, Books, 659898, Company Histories, 659886, Biographies & Histories, 68, Business, Finance & Law, 1025612, Subjects, 266239, Books, 922084, Biotechnology, 277912, Biological Sciences, 57, Science & Nature, 1025612, Subjects, 266239, Books, 278116, Bioengineering, 278115, Engineering & Technology, 57, Science & Nature, 1025612, Subjects, 266239, Books, 922320, Manufacturing, 922314, Production, Manufacturing & Operational, 278115, Engineering & Technology, 57, Science & Nature, 1025612, Subjects, 266239, Books, 772136, History of Science, 922508, History & Philosophy, 57, Science & Nature, 1025612, Subjects, 266239, Books

Neues Buch Amazon.co.uk
-SuperBookDeals-
Neuware. Versandkosten:Europa Zone 1: GBP 5,48 pro Produkt.. Usually dispatched within 1-2 business days. Die angegebenen Versandkosten können von den tatsächlichen Kosten abweichen. (EUR 4.80)
Details...
(*) Derzeit vergriffen bedeutet, dass dieser Titel momentan auf keiner der angeschlossenen Plattform verfügbar ist.

Details zum Buch
Genentech: The Beginnings of Biotech (Synthesis)

Genentech In the fall of 1980, Genentech, Inc, a little-known California genetic engineering company, became the overnight darling of Wall Street, raising $38 million in its initial public stock offering. This title provides portraits of the people significant to Genentech's science and business, and focuses on how personality affects the growth of science. Full description

Detailangaben zum Buch - Genentech: The Beginnings of Biotech (Synthesis)


EAN (ISBN-13): 9780226045511
ISBN (ISBN-10): 022604551X
Gebundene Ausgabe
Taschenbuch
Erscheinungsjahr: 2013
Herausgeber: University of Chicago Pr.
213 Seiten
Gewicht: 0,320 kg
Sprache: Englisch

Buch in der Datenbank seit 14.11.2007 14:54:56
Buch zuletzt gefunden am 07.12.2017 02:39:45
ISBN/EAN: 9780226045511

ISBN - alternative Schreibweisen:
0-226-04551-X, 978-0-226-04551-1


< zum Archiv...
Benachbarte Bücher